Another day, another Honorable Mention from @awwwards 🎉. This time, it’s for @MatrixSpaceAI.
The shoutout comes after the brand & web design updates we worked on to make MatrixSpace’s radar technology clear for its target audiences and help them provide the best user experience for their customers.
There’re more what that came from. Explore the rest of our work https://t.co/WqX8bbkOQI.
#Awwwards #DesignAward #BRIGHTSCOUT #WebDesign #BrandIdentity #B2BTech
Join this webinar by @VeriSIMlife to learn how exactly AI and ML techniques are taking computational modeling and informatics to new domains of applicability in the drug development lifecycle.
🔗 https://t.co/Udq8Q7wNRv
#DrugDevelopment#Preclinical#DrugDiscovery#Toxicology
We we have to innovate our way out of the current equation that puts intense demand on capital for biotechs to bring their science to market. https://t.co/3v0HAuQT1r
Great story from @amancaytapi on the outlook for #ai to help address #drugshortages, high costs, and more: The Obvious, But Quiet, Entry of AI in Pharma https://t.co/WiGSLH3qf5
VeriSIM Life is excited to announce a free webinar June 7th, "Mitigating translational risk in drug development with AI-enabled MIDD" led by CEO & Founder Dr. Jo Varshney and Aridhia Chief Science Officer, Dr. Jeff Barrett. Learn more & register now! https://t.co/dSSqiVWE5z
Excited that the publication "Development of an Accurate AI/ML-Driven COVID-19 Patient Stratification Model Predicting Disease Outcomes from Disproportionate and Scarce Clinical Datasets" by VeriSIM Life team members made the SSRN Top Ten Download List! https://t.co/WzoYR15RTz
We're evolving our Translational Index technology to better evolve our clients' drug asset programs. Check out this article to see how. https://t.co/dNWK13oJ01
“AI is only as good as the data, but it’s not *just* about the data,” says VeriSIM Life CEO & founder Dr. Jo Varshney. Read more from "Artificial Intelligence Trends to Leverage in 2023": https://t.co/0QFmSOGwZn
AI-driven #biomarker discernment (biomarker discovery and correlation to therapy response) is one of the most exciting applications for #deeptech. A recent study from researchers with Emory University, Cleveland Clinic, NYU Langone…https://t.co/iI27vmfT8L https://t.co/JZHoUlSEjd
Wow. #ChatGPT just passed the Medical Licensing Exam... without studying.
We're not ready to turn doctoring over the machine, but #AI's ability to assist is mindbending. https://t.co/Xas5Ltjlpq
Compelling research on the connection between COVID and the puzzling US economic signals we've digested recently. Notable is the estimated impact of Long COVID on the workforce. https://t.co/Neu2tcZX9f
The secret to better health is escaping the healthcare matrix. Fascinating data from McKinsey that suggests we can add 6 years of higher-quality life to the globe's population by focusing on mental, social and spiritual health, ver…https://t.co/J5XpmqsJkh https://t.co/O04lSw2J5J
Really interesting perspective from one of LIDAR's pioneers on how far the technology will (not) enable autonomy. Apparently, Musk is not alone. If only we had a lighter alternative to glass... 🤔 cc Iris Automation Inc https://t.co/QE7PtZfZdA
Telemetry data is rad. Fluming the abundance of it is not. Observability pipelines make data proliferation manageable. Nice to see an OSS-native alternative to Cribl now available for enterprises. https://t.co/sV9l5dA6i1
Congrats to the team at @VeriSIMlife for winning Predictive Analytics Solution of the Year. https://t.co/EEBtmL3LEE Drug discovery and development is truly being transformed by machine learning. That's a win for patients!